LogiPharma 2017 US

October 04 - 06, 2017

Westin Philadelphia, PA

Contact: 1.888.482.6012

Summer Sale: Life Science companies save $300 by registering early! Use code: SUMMER

 

Supply Chain Optimization to Contain Costs in an Ever Changing Healthcare Environment

Wednesday, October 4, 2017

Expand All Sessions [+] Collapse All Sessions [-]

7:00 AM Registration & Breakfast In The LogiLounge

8:00 AM Welcoming Remarks

Marissa Alvord, Executive Director, LogiPharma USA

 Marissa Alvord
Marissa Alvord
Executive Director
LogiPharma USA
Marissa Alvord is Program Director for LogiPharma, LogiMed and FIMA. With over seven years of conference production experience, Marissa specializes in market research in the financial, pharmaceutical, biotech and medical device industries. Marissa cut her teeth in conference production working for a small publishing house in London producing events ...[Read More]

8:05 AM Ice Breaker

Just how well do you know the City of Brotherly Love? Team up with fellow attendees for our Philadelphia Quiz Ice Breaker! Meet new connections and have a few laughs along the way as you put your Philly knowledge to the test. The winning table will enjoy a bubbly prize!

8:25 AM Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Liam Birt at 646-200-7455 or liam.birt@wbresearch.com to find out about how to get involved as emcee.

8:40 AM Fireside Chat | Understanding Emerging Global Healthcare Trends to Remain Competitive

Scott Chilson, Vice President, Customer Connectivity, Johnson & Johnson

Mike Douma, Vice President, Supply Chain, AbbVie, Inc

Growth through acquisition has been the strategy of the pharma industry for years, and few new products are coming out from big pharma. As pricing comes under increased scrutiny under the new Administration, cost pressures will become even greater. How can the industry maintain margins and cut out supply cost? How can companies cost effectively become more patient centric? How can the industry control costs as novel therapies, including biologics, personalized medicine, cell and gene therapies require new supply chain strategies? Two Heads of Supply Chain will weigh in on what they’re scrutinizing and how they are preparing for the future, including:
Macro trends impacting shipping and distribution
The ‘patient of the future’ and how to meet future needs
Key opportunities to advance supply chain strategy over the next ten years
Areas of investment to remain competitive
How to ensure you remain current with disruptive technologies and innovations

 Scott Chilson
Scott Chilson
Vice President, Customer Connectivity
Johnson & Johnson
Scott Chilson currently serves as Vice President, Customer Connectivity, Customer and Logistics Services (CLS). In his role, Scott is responsible for developing the strategy and key programs to deliver outstanding performance in Johnson & Johnson’s customer experience.  He has accountability for our Global Customer Service strategy, Supply Cha ...[Read More]

 Mike Douma
Mike Douma
Vice President, Supply Chain
AbbVie, Inc
Mike Douma is Vice President, Supply Chain, AbbVie Operations. Mike leads a team responsible for third party manufacturing, planning, warehousing and distribution, including customer service and AbbVie’s Specialty Pharmacy.
 
Mike has held various manufacturing leadership positions with responsibilities in the United St ...[Read More]

9:10 AM Revising Supply Chain Strategies to Plan for 2020 and Beyond

Mike Douma, Vice President, Supply Chain, AbbVie, Inc

Many big pharma companies are planning for a bulk of revenues to come from biologics and large molecule therapies in the next few years, which has huge implications for the supply chain. How do you stand up a biologics supply chain while building out small molecule supply chains in emerging markets given global market conditions? How can you be confident that you’ve mapped enough long-term capacity for biologics?
Find out how one supply chain leader is planning for 2020, including:
Maintaining infrastructure for small molecule production and distribution when launching products in other markets
Maximizing spend and vendor relationships on a global scale, from governance issues to oversight where there are matrixed reporting lines
Product rationalization to maximize opportunities

 Mike Douma
Mike Douma
Vice President, Supply Chain
AbbVie, Inc
Mike Douma is Vice President, Supply Chain, AbbVie Operations. Mike leads a team responsible for third party manufacturing, planning, warehousing and distribution, including customer service and AbbVie’s Specialty Pharmacy.
 
Mike has held various manufacturing leadership positions with responsibilities in the United St ...[Read More]

9:30 AM Panel Discussion | Advancing the Supply Chain in an Age of Reverse Globalization

Kevin Cook, VP Supply Chain North America, Sandoz

Juan Fernando Forero, Vice President, Network Supply Operations, Pfizer Innovative Health, Pfizer, Inc.

Michael Orlowski, Vice President, Supply Chain and Technical Operations, Daiichi Sankyo, Inc

2016 brought about significant political change on a global level that has serious implications for supply chain management. Brexit and the proposed changes by the new Administration are challenging the notion of globalization in a shift to a more nationalist approach, changing the way supply chains and businesses work. How are companies preparing for this change? What are the implications for supply chain? What needs to be in place for a supply chain to be agile to quickly respond to change? An economist, government affairs executive and supply chain leaders will discuss how these changes will impact the supply chain.
Panelists will discuss the ways in which:
Their firms are reacting to new changes
Costs are being assessed for offshoring versus reshoring
Supply chain network plans are being re-evaluated

 Kevin Cook
Kevin Cook
VP Supply Chain North America
Sandoz
Kevin has over 25 years’ experience in the Life Sciences Industry and is passionate about advancing the role of Supply Chain for competitive, business growth while meeting our patient needs.   Kevin's career in healthcare spans supply chain management, customer service, distribution, planning and manufacturing. 

...[Read More]

 Juan Fernando Forero
Juan Fernando Forero
Vice President, Network Supply Operations, Pfizer Innovative Health
Pfizer, Inc.
Juan is the Supply Chain Leader Pfizer Innovative Health (PIH). Juan joined Pfizer in 1993 as a supervisor at the Cali, Colombia site and held several positions of increasing responsibility in manufacturing and materials management, including production planning and scheduling, customer service, new products/transfers, warehousing and distribu ...[Read More]

 Michael Orlowski
Michael Orlowski
Vice President, Supply Chain and Technical Operations
Daiichi Sankyo, Inc

Mike Orlowski is the Vice President of Supply Chain and Technical Operations, accountable for making and delivering all current and future medicines to Daiichi Sankyo, Inc.’s customers.
With more than twenty years' experience in pharmaceutical supply chain, quality assurance, and finance, Mike has performed in ...[Read More]

10:10 AM Panel Revolution | Adapting Supply Chain Strategies in the Context of Reverse Globalization

10:25 AM Morning Refreshment & Networking Break In The LogiLounge

11:05 AM Parcel and Pharma / Becoming More the ‘Norm’ for Delivering Pharmaceuticals?

Steve Williamson, Director, Solution Consulting, BluJay Solutions

Are you seeing the trend of consumers getting their pharmaceuticals via the web? Phone in? Has the trend of picking up the medications at a pharmacy or doctor’s office changed for your business? Can these changes be supported by your outbound parcel system? 
Hear more about the latest in delivery, including:
Adult Signature Required
Last Mile Delivery Options
Multi Carrier
Proof Of Delivery

 Steve Williamson
Steve Williamson
Director, Solution Consulting
BluJay Solutions
With over 20 years in the industry, Steve Williamson is a recognized industry expert in parcel shipping; investigating and designing many workflows and solutions for high volume, complex customers.

Steve has also worked for BluJay Solutions in Europe bringing a complete view of the complexities not only affecti ...[Read More]

11:25 AM Voice of the Provider | Supply Chain Optimization to Keep Ahead of Current & Future Healthcare Trends

William Mosser, Vice President, Materials Management, FMOLHS

Cost containment is the top priority for all supply chain leaders in healthcare, particularly when drug costs increase each year. New standards, including global serialization rules are creating a shift in the marketplace suggesting that the industry is ready for change. William Mosser, Vice President, Materials Management, FMOL- Health System has been partnering more closely with medical device companies and is looking to work directly with pharmaceutical companies. In this session, William will draw the curtains open to shed light on current healthcare legislation and how it’s affecting providers and how IDNs are optimizing supply chain strategies.
Gain key insights including:
What financials look like within hospitals 
Regulatory impacts of data requirements
Priorities for supply chain optimization 
How to partner with providers to cut costs and provide better patient care

 William Mosser
William Mosser
Vice President, Materials Management
FMOLHS
Bill Mosser is Vice President Supply Chain Services at Franciscan Missionaries of Our Lady Health System, in Baton Rouge, Louisiana. FMOLHS is comprised of five hospitals and many non-acute care entities with $600 million in annual supply and services spend. Prior to joining FMOLHS, Bill served in similar roles at Temple University Health System in ...[Read More]

11:45 AM Controlling Your Own Fate by Rotating to the New

Brad Pawlowski, Managing Director, Life Sciences Supply Chain, Accenture

Jennifer Donatelli, Managing Director, Strategy Supply Chain, Accenture

New digital innovations are causing many disruptions while at the same time they bring us a whole new portfolio of possibilities.  The burning question is, how will future supply chains leverage these innovations to align consumer demand and supply realities in an agile way? Are you prepared?
 Brad Pawlowski
Brad Pawlowski
Managing Director, Life Sciences Supply Chain
Accenture
Brad Pawlowski is Managing Director in Accenture’s Life Science Supply Chain practice and a recognized expert on Business Transformation programs. The global leader of Accenture’s Supply Chain Planning and Advanced Analytics practice, Brad has broad experience managing international teams in diverse industries and markets, including healthcare/life ...[Read More]

 Jennifer Donatelli
Jennifer Donatelli
Managing Director, Strategy Supply Chain
Accenture
Jennifer Donatelli is a Managing Director with over 16 years of Supply Chain experience.  Jennifer is part of Accenture's Operations Strategy practice, specialized in Life Sciences, BioTech, Pharma, and Medical Device. She is focused on supply chain strategy and transformation programs for global Life Sciences clients, with deep expertise in S&OP, ...[Read More]

12:05 PM Interactive Roundtable Discussions

(Choose 2, 30 minutes each)

Mark Holder, Executive Director, Regional Supply North America, AstraZeneca

Steve Williamson, Director, Solution Consulting, BluJay Solutions

Brad Pawlowski, Managing Director, Life Sciences Supply Chain, Accenture

Jennifer Donatelli, Managing Director, Strategy Supply Chain, Accenture

Erica Olson, Vice President, GMS Strategy and Business Development, GSK

Eric Allen, Vice President, Sales & Marketing, Aphena Pharma Solutions

Ed Ram, Senior Supply Chain Director, Sagent Pharmaceuticals

Richard Codner, Director, Distribution, Merck & Co

Interested in demonstrating thought leadership facilitating a conversation with a group of supply chain leaders as a roundtable discussion host? Contact Liam Birt, 646-200-7455 or liam.birt@wbresearch.com


#1  Preparing for 2020 and Beyond, Preparing for New Revenue Streams
Mark Holder, Executive Director, Regional Supply North America, AstraZeneca

#2  Parcel and Pharma / Becoming More the ‘Norm’ for Delivering Pharmaceuticals?
Steve Williamson, Director, Solution Consulting, BluJay Solutions

#3  Controlling Your Own Fate by Rotating to the New
Brad Pawlowski, Managing Director, Life Sciences Supply Chain, Accenture
Jennifer Donatelli, Managing Director, Strategy Supply Chain, Accenture

#4  Understanding Supply Chain Global Political Impact Related to Brexit and New US Administration 
Erica Olson, Vice President, GMS Strategy and Business Development, GSK

#5  Best Practices to Better Manage CMO Performance, From Cost Improvements to Serialization Compliance 
Eric Allen, Vice President, Sales & Marketing, Aphena Pharma Solutions
Ed Ram, Senior Director, Supply Chain, Sagent Pharmaceuticals

#6  Risk of Imports of Pharmaceuticals to the US, and Supply Chain Mitigation Strategies
Richard Codner, Director, Distribution, Merck & Co

#7  How to Account for a Range of Temperature Control Needs and Scenarios

#8  Bridging the Gap Between Commercial and Clinical Supply Chain to Best Meet the Needs of Patients

 Mark Holder
Mark Holder
Executive Director, Regional Supply North America
AstraZeneca
Mark is accountable for the leadership of the North American Demand Team responsible for the interface between Operations and the North American Commercial Organization managing the following key responsibilities:  
Directing demand m ...[Read More]

 Steve Williamson
Steve Williamson
Director, Solution Consulting
BluJay Solutions
With over 20 years in the industry, Steve Williamson is a recognized industry expert in parcel shipping; investigating and designing many workflows and solutions for high volume, complex customers.

Steve has also worked for BluJay Solutions in Europe bringing a complete view of the complexities not only affecti ...[Read More]

 Brad Pawlowski
Brad Pawlowski
Managing Director, Life Sciences Supply Chain
Accenture
Brad Pawlowski is Managing Director in Accenture’s Life Science Supply Chain practice and a recognized expert on Business Transformation programs. The global leader of Accenture’s Supply Chain Planning and Advanced Analytics practice, Brad has broad experience managing international teams in diverse industries and markets, including healthcare/life ...[Read More]

 Jennifer Donatelli
Jennifer Donatelli
Managing Director, Strategy Supply Chain
Accenture
Jennifer Donatelli is a Managing Director with over 16 years of Supply Chain experience.  Jennifer is part of Accenture's Operations Strategy practice, specialized in Life Sciences, BioTech, Pharma, and Medical Device. She is focused on supply chain strategy and transformation programs for global Life Sciences clients, with deep expertise in S&OP, ...[Read More]

 Erica Olson
Erica Olson
Vice President, GMS Strategy and Business Development
GSK
Erica Olson joined GlaxoSmithKline in 2000 and currently leads the Global Manufacturing & Supply Strategy, Core Commercial Cycle (S&OP), and Business Development.  Her previous experience includes leading shared services and key initiatives in logistics, planning, end-to-end design, analytics, research, benchmarking and talent development.  Under E ...[Read More]

 Eric Allen
Eric Allen
Vice President, Sales & Marketing
Aphena Pharma Solutions
Eric Allen was named VP of Sales & Marketing of Aphena Pharma Solutions in 2013 after being with Aphena since 2005.  He has over 15 years in the pharmaceutical and dietary packaging industry and 10 years managing a sales and marketing groups for a Fortune 500 company.  At Aphena, he has been leading the marketing team, servicing government contract ...[Read More]

 Ed Ram
Ed Ram
Senior Supply Chain Director
Sagent Pharmaceuticals
Ed Ram is Senior Director, Supply Chain at Sagent Pharmaceuticals near Chicago, Illinois.  He is responsible for their global supply chain -- production planning and moving finished goods from India, China, Europe, and South America to and throughout North America.  
Ed has over 20 years of supply chain and strategic sourcing exper ...[Read More]

 Richard Codner
Richard Codner
Director, Distribution
Merck & Co
Richard Codner is Executive Director of Distribution and Logistics for Europe at Merck & Co.
He is responsible for Merck's quota system in Europe, the first such system in pharma.
His various responsibilities included leading the Route to Customer initiative to create efficiencies in the end-to-end supply chain and to partner with wh
...[Read More]

1:10 PM Lunch

Track A: Next Generation Supply Chain Planning

2:10 PM Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Liam Birt at 646-200-7455 or liam.birt@wbresearch.com to find out about how to get involved as emcee.

Track B: Improving Temperature Control Processes While Containing Costs

Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Liam Birt at 646-200-7455 or liam.birt@wbresearch.com to find out about how to get involved as emcee.

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

(By Invitation Only)
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

Track A: Next Generation Supply Chain Planning

2:20 PM Panel Discussion | Connecting Business KPIs to Advance Demand Planning

Michele Dorris, Executive Director, Supply Chain, Sandoz, Novartis Division

Claire Pairaud, Head, Sales and Operations Planning North America, Genentech

Jen Wang, Vice President, Global Planning, Allergan, Inc.

Many companies continue to struggle with demand timing and cost competitiveness. How can you better forecast manufacturing with what sales actually does? What kinds of metrics will allow you to measure the health of your forecast? 
Panelists will discuss:
How to best interface between commercial and supply planning
Opportunities from people and process perspectives to mature demand planning
“Greatest Hits” or what best practices they’ve continued from previous roles

 Michele Dorris
Michele Dorris
Executive Director, Supply Chain
Sandoz, Novartis Division
Michele has over 25 years of experience with Supply Chain roles in several industries – chemical, consumer package, and pharmaceutical.  Currently she is Executive Director of Customer Operations and Demand Planning at Sandoz Pharmaceutical, a Division of Novartis.  Prior to her current role at Sandoz , she was Director of Commercialization an ...[Read More]

 Claire Pairaud
Claire Pairaud
Head, Sales and Operations Planning North America
Genentech
A Biochem Engineer by training, Claire spent 16 years in scientific instrument customer support and operations at Applied Biosystems (now ThermoFisher) before joining Genentech’s Contract Manufacturing (CMO) team in 2006. From 2006 to 2013, she led CMO Strategy, Operational Excellence, Business Process Management and Materials Management, work ...[Read More]

 Jen Wang
Jen Wang
Vice President, Global Planning
Allergan, Inc.
Jen  is Vice President, Global Planning with global responsibility for supply and demand planning, S&OP, and inventory optimization.  Jen has been involved in integration of Allergan, Forest, Warner Chilcott, and Actavis in her 5 years with the company and led the deployment of Global S&OP process.  Prior to that, Jen was with Johnson & Johnso ...[Read More]

Track B: Improving Temperature Control Processes While Containing Costs

Panel Discussion | Air v. Ocean, Active v. Passive, Managing Risk and Optimizing Costs

Ben Vanderplas, Global Product Manager, Sonoco Thermosafe

The air versus ocean debate is ongoing and many are moving to ocean freight to achieve cost savings and utilize active shipping containers. How can you utilize a combination of both approaches to contain costs while ensuring product integrity? When should you use active versus passive? How do you mix and match shipping methods along the journey to increase economies of scale without compromising product integrity? What are companies doing to increase ocean freight?
Find out how to:
Consider a range of global regulatory requirements
Understand and manage the risks of either channel 
Access non-traditional temperature control methods while maintaining integrity and efficacy

 Ben Vanderplas
Ben Vanderplas
Global Product Manager
Sonoco Thermosafe
Ben VanderPlas is the Global Product Manager for Sonoco ThermoSafe.  He started with the company in 2005 and has had various roles within the organization including engineering, sales, and marketing. In his current role, Ben is responsible for the development and sales of Sonoco ThermoSafe’s pre-qualified solutions.  From the Institute of Packaging ...[Read More]

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

Continued
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

Track A: Next Generation Supply Chain Planning

3:00 PM Innovation Spotlight Showcase

Over the course of 20-minutes, hear from two innovative companies showcasing the latest in demand planning and S&OP solutions during a 10-minute spotlight. To find out more about showcasing your solution, contact Liam Birt, 646-200-7455 or liam.birt@wbresearch.com

Track B: Improving Temperature Control Processes While Containing Costs

Gaining Inventory Visibility and Achieving Savings on Reusable Temperature Controlled Packaging

Kevin Lawler, Vice President, Worldwide Sales, Pelican BioThermal

 Kevin Lawler
Kevin Lawler
Vice President, Worldwide Sales
Pelican BioThermal
Kevin Lawler is the Vice President of Worldwide Sales at Pelican BioThermal. During his nearly eight years with Pelican BioThermal, the company has achieved average year-to-year skyrocketing growth rates of over 40 percent. With more than 25 years of successful sales leadership experience, Kevin has a strong history in building and leading sales or ...[Read More]

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

Continued
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

Track A: Next Generation Supply Chain Planning

3:10 PM Innovation Spotlight Showcase

Continued
Over the course of 20-minutes, hear from two innovative companies showcasing the latest in demand planning and S&OP solutions during a 10-minute spotlight. To find out more about showcasing your solution, contact Liam Birt, 646-200-7455 or liam.birt@wbresearch.com

Track B: Improving Temperature Control Processes While Containing Costs

Industry Update By DHL

Executive Speaker to be Confirmed, DHL

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

Continued
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

Track A: Next Generation Supply Chain Planning

3:20 PM Preparing for Launch, Improving Collaboration for a Seamless Launch

Tiffany Cavallaro, Director, Supply Chain, Amgen

Bringing new products to market is one of the most critical activities for a biopharma company and the biggest challenge is ensuring things happen on time and effectively.  What are some of the innovative approaches being used to take products to market? Where does turnover from R&D, planning and operations happen? How do you get planning involved?
Find out:
How to best project manage launch readiness
Skills and competencies needed to support an agile organization
Lessons learned from generics, where speed to market is critical

 Tiffany Cavallaro
Tiffany Cavallaro
Director, Supply Chain
Amgen
Tiffany Cavallaro is Director of US Supply Chain at Amgen. In this role she oversees demand planning, supply planning, new product launches and life cycle management activities for finished goods distributed in the US market.

Tiffany has over 15 years of experience working in the pharmaceutical industry spannin ...[Read More]

Track B: Improving Temperature Control Processes While Containing Costs

Industry Update By DHL

Continued
Executive Speaker to be Confirmed, DHL

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

Continued
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

Track A: Next Generation Supply Chain Planning

3:30 PM Preparing for Launch, Improving Collaboration for a Seamless Launch

Continued

Tiffany Cavallaro, Director, Supply Chain, Amgen

Bringing new products to market is one of the most critical activities for a biopharma company and the biggest challenge is ensuring things happen on time and effectively.  What are some of the innovative approaches being used to take products to market? Where does turnover from R&D, planning and operations happen? How do you get planning involved?
Find out:
How to best project manage launch readiness
Skills and competencies needed to support an agile organization
Lessons learned from generics, where speed to market is critical

 Tiffany Cavallaro
Tiffany Cavallaro
Director, Supply Chain
Amgen
Tiffany Cavallaro is Director of US Supply Chain at Amgen. In this role she oversees demand planning, supply planning, new product launches and life cycle management activities for finished goods distributed in the US market.

Tiffany has over 15 years of experience working in the pharmaceutical industry spannin ...[Read More]

Track B: Improving Temperature Control Processes While Containing Costs

Case Study | Designing a Cold Chain Process to Meet the Unique Needs of Cell and Gene Therapy Treatments

Michael Trocchia, Director, Supply Chain, Novartis

Cold chain and temperature control processes are making new strides as biologics and other cutting edge therapies come to market. Cell and gene therapies are among the most innovative and exciting therapies in development and they require a completely new cold chain and supply chain strategy. Samples need to be taken from patients, treated and returned to patients and any disruptions will have serious and negative consequences for vulnerable patients. How can you ensure this process is seamless? How can this process be commercialized once therapies are approved? 
Find out how to:
Design a project scheduling system to meet unique patient needs
Overcome the challenges of tracking chain of identity
Replicate this process on a larger scale

 Michael Trocchia
Michael Trocchia
Director, Supply Chain
Novartis
Mike started his career with Novartis in 1984 as a process engineer at the then Ciba-Geigy facility in Summit NJ.  
Mike then went on to manage all Commercial Manufacturing operations at the Summit site before the site was closed and operations moved to alternate Novartis facilities.
Mike then moved to the Suffern, NY s ...[Read More]

Supply Chain Leaders Boardroom

Supply Chain Leaders Boardroom

Continued
The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com  

3:50 PM Afternoon Refreshment & Networking Break In LogiLounge

General Session

4:30 PM Case Study | Consolidating the Supply Chain, Shifting Away from a Decentralized Model

Kevin Cook, VP Supply Chain North America, Sandoz

As cost pressures increase, companies across the industry are looking for economies of scale and cost containment through centralized supply chains and shared service models. Novartis, Alcon and Sandoz have consolidated the supply chain footprint and are working toward a 2020 savings target. Find out lessons learned and key successes in this major supply chain transformation, including:
Optimizing the number of distribution centers
How to make it work when there are competing priorities in the absence of contracts

 Kevin Cook
Kevin Cook
VP Supply Chain North America
Sandoz
Kevin has over 25 years’ experience in the Life Sciences Industry and is passionate about advancing the role of Supply Chain for competitive, business growth while meeting our patient needs.   Kevin's career in healthcare spans supply chain management, customer service, distribution, planning and manufacturing. 

...[Read More]

Creative Boardroom Part I

Designing a Supply Chain Staffing Model for Small to Mid-Sized Companies

Joseph Barry, Director, Supply Chain Operations, Amicus Therapeutics

Jason Cameron, Vice President, Global Supply Chain, Amicus Therapeutics

Limited to 15 supply chain practitioners from manufacturers only, sign up at registration to share best practices and problem solve with peers battling similar challenges.

Understanding the skillsets and capabilities needed for smaller supply chain teams
Identifying critical skillsets that are needed now and mapping them to the future
Handling make vs. buy decisions when it comes to in-house talent and consulting

Joseph Barry
Director, Supply Chain Operations
Amicus Therapeutics

Jason Cameron
Vice President, Global Supply Chain
Amicus Therapeutics

General Session

4:50 PM Driving Lean and Operational Excellence Activities to Reduce Costs

Linzell Harris, Senior Vice President, Global Supply Chain, Teva Pharmaceuticals

Lean margins mean the need for an efficient supply chain. The continuous improvement mentality is housed in the supply chain organization, but how can you expand the reach to drive out waste? 
Find out how to:
Achieve cost savings without reducing headcounts
Create a Lean culture and make the concepts stick
Drive lead times through value stream mapping 
Identify non-value added activities to improve efficiencies

 Linzell Harris
Linzell Harris
Senior Vice President, Global Supply Chain
Teva Pharmaceuticals
Linzell has more than 25 years of diverse general management and global operations experience in the CPG, Pharmaceutical and luxury goods industries. Since August 2015, he has served as the head of the Global Supply Chain team at Teva Pharmaceuticals, managing one of the most comprehensive supply chain networks in the pharmaceutical industry. ...[Read More]

Creative Boardroom Part I

Designing a Supply Chain Staffing Model for Small to Mid-Sized Companies

Continued

Joseph Barry, Director, Supply Chain Operations, Amicus Therapeutics

Jason Cameron, Vice President, Global Supply Chain, Amicus Therapeutics

Limited to 15 supply chain practitioners from manufacturers only, sign up at registration to share best practices and problem solve with peers battling similar challenges.

Understanding the skillsets and capabilities needed for smaller supply chain teams
Identifying critical skillsets that are needed now and mapping them to the future
Handling make vs. buy decisions when it comes to in-house talent and consulting

Joseph Barry
Director, Supply Chain Operations
Amicus Therapeutics

Jason Cameron
Vice President, Global Supply Chain
Amicus Therapeutics

5:10 PM LogiPharma Welcome Reception in the LogiLounge

After a day filled with keynotes, breakouts and panels take a moment to celebrate with your new friends! Join us in the LogiLounge for a chance to connect with some of the biopharma industry’s finest leaders. Now’s the time to network with peers
and clients at one of the largest and most informative supply chain meetings in the industry.

6:10 PM Conclusion Of Day One



















Live Chat Software